Informa TechTarget

Sep 15, 2026

Informa TechTarget

Deep Dive Opinion Library Press Releases Events Ai index Ai Daily White Paper Ai Certification Research Report Library Resources Ranking List

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

Informa TechTarget 中文

Deep Dive
Opinion
Library
Press Releases
Events
Ai index
Ai Daily
White Paper
Ai Certification
Research Report
Library Resources
Ranking List

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

White Paper

No content available

Press Releases

NeuroGT Announces FDA Clearance of Investigational New Drug Application for NGT-104, an AAV9 Gene Replacement Product for MPS IIIB | BioPharma Dive

TSRL Secures Second-Year NIH Award to Advance Microneedle Patch for Overactive Bladder Treatment

Toralgen Demonstrates Oral Delivery Across Multiple Diabesity Peptide Classes, Advancing the Potential of Oral Biologics | BioPharma Dive

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen | BioPharma Dive

Most Popular

Regeneron to challenge Ipsen as FDA clears bone disease drug Cancer vaccine win restores Wall Street’s faith in Moderna Ultragenyx, after setbacks, nabs first gene therapy approval Trump nominates policy aide Overton to lead FDA

Latest News

Trailing rivals, AbbVie scores win with dual-acting myeloma drug

This week in charts: China deals, stock flatlines and Lilly’s M&A spree

Ionis’ rare neurology drug approved; Pfizer inks an ADC deal

NeuroGT Announces FDA Clearance of Investigational New Drug Application for NGT-104, an AAV9 Gene Replacement Product for MPS IIIB | BioPharma Dive

Informa TechTarget

Informa TechTarget©2026-2046